Vigil Neuroscience (VIGL) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Vigil Neuroscience Revenue Highlights


00

Vigil Neuroscience Revenue by Period


Vigil Neuroscience Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--

Vigil Neuroscience generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Vigil Neuroscience Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$1.93M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30--

Vigil Neuroscience generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Vigil Neuroscience Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TRDAEntrada Therapeutics$129.01M$94.69M
MOLNMolecular Partners$7.04M$2.74M
PRTCPureTech Health$3.33M$178.57K
OPTOpthea$108.41K$61.27K
CGEMCullinan Oncology--
PHVSPharvaris--
RLYBRallybio-$299.00K
PMVPPMV Pharmaceuticals--
VIGLVigil Neuroscience--
THRDThird Harmonic Bio--
GLUEMonte Rosa Therapeutics-$4.70M
CMPXCompass Therapeutics--
EWTXEdgewise Therapeutics--
PEPGPepGen--
TYRATyra Biosciences--

VIGL Revenue FAQ


Vigil Neuroscience's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. VIGL's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Vigil Neuroscience's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). VIGL's quarterly revenue for Q4 2023 was $1.93M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

Vigil Neuroscience's revenue growth rate for the last 3 years (2021-2023) was 0%